VERU INC. Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- VERU INC. treasury stock, value, acquired, cost method for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- VERU INC. treasury stock, value, acquired, cost method for the quarter ending 2015-12-31 was $0.00.
- VERU INC. treasury stock, value, acquired, cost method for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- VERU INC. treasury stock, value, acquired, cost method for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- VERU INC. treasury stock, value, acquired, cost method for fiscal 2015 was $950.00, a 99.87% decline from fiscal 2014.
- VERU INC. treasury stock, value, acquired, cost method for fiscal 2014 was $737.75K, a 86.46% increase from fiscal 2013.
- VERU INC. treasury stock, value, acquired, cost method for fiscal 2013 was $395.67K, a 36.62% increase from fiscal 2012.
- VERU INC. treasury stock, value, acquired, cost method for fiscal 2012 was $289.61K.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2016-03-31 | $0.00 derived: 10-Q 111 month − 10-Q 108 month · filed 2016-04-28 | $0.00 derived: sum of 4 quarters · filed 2018-01-02 |
| 2015-12-31 | $0.00 derived: 10-Q 108 month − 10-Q 105 month · filed 2016-02-02 | $950.00 derived: sum of 4 quarters · filed 2018-01-02 |
| 2015-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | $950.00 10-K · filed 2018-01-02 |
| 2015-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-07-30 | $520.86K derived: sum of 4 quarters · filed 2016-12-12 |
| 2015-03-31 | $950.00 10-Q · filed 2015-07-30 | $728.33K derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-12-31 | $0.00 derived: 10-Q 96 month − 10-Q 93 month · filed 2015-02-03 | $737.75K derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-09-30 | $519.91K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | $737.75K 10-K · filed 2016-12-12 |
| 2014-06-30 | $207.47K 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $10.37K 10-Q · filed 2014-07-31 | |
| 2013-12-31 | $0.00 derived: 10-Q 84 month − 10-Q 81 month · filed 2014-02-03 | |
| 2013-09-30 | $395.67K 10-K · filed 2015-12-02 | |
| 2012-09-30 | $289.61K 10-K · filed 2014-12-02 | |
| 2011-09-30 | -$33.06K 10-K · filed 2013-12-03 | |
| 2010-09-30 | -$349.06K 10-K · filed 2012-12-04 | |
| 2009-09-30 | -$3.83M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |